Many biological investigations require 3D imaging of cells or tissues with nanoscale spatial resolution. We recently discovered that preserved biological specimens can be physically expanded in an isotropic fashion through a chemical process. Expansion microscopy (ExM) allows nanoscale imaging of biological specimens with conventional microscopes, decrowds biomolecules in support of signal amplification and multiplexed readout chemistries, and makes specimens transparent. We review the principles of how ExM works, advances in the technology made by our group and others, and its applications throughout biology and medicine.
O ptical microscopy techniques make up one of the most important toolsets in the history of biology and medicine. Until recently the diffraction limit posed by physics limited the resolution of optical microscopes to values of a few hundred nanometers-far greater than the size of biological molecules. The development of near-field imaging 1,2 and a suite of far-field superresolution microscopy techniques 3, 4 have enabled researchers to optically image single molecules and nanoscale structures in biology. Although powerful, such technologies typically require expensive equipment and/or have slow imaging speeds; 3D super-resolution imaging, especially of specimens of tissues and organs, remains a challenge. Recently we discovered that it is possible to physically magnify a preserved biological specimen 5 in an even fashion by synthesizing a dense, cross-linked network of swellable polyelectrolyte hydrogel throughout such a specimen (Fig. 1a ). This in turn can smoothly and isotropically expand biomolecules or labels away from each other after chemical processing. After such physical magnification, molecules in a diffraction-limited region are separated in space to greater distances, and therefore can be resolved even by conventional diffraction-limited microscopes.
The ExM approach brings together two different fields: the physics of swellable polyelectrolyte hydrogels, which vastly increase in size when immersed in a solvent such as water and which were explored in depth by groups such as that of Toyoichi Tanaka in the late 1970s 6 , and the embedding of preserved biological specimens in polymer hydrogels for imaging purposes, pioneered by teams such as that of Peter Hausen and Christine Dreyer, who used uncharged polyacrylamide hydrogels to facilitate tissue staining and imaging in the early 1980s 7 . Such gels have polymer spacings (or mesh sizes) that are quite small-approximately 1-2 nm (ref. 8 )-which leads us to think that the errors introduced by in situ polymerization and expansion could in principle also be quite small, perhaps on the order of the size of a biomolecule.
Over the past few years, we have developed a diversity of ExM protocols that enable imaging of proteins 9 and RNAs 10 , that can physically magnify objects multiple times in succession to achieve very high resolution 11 , or that can be applied to human clinical specimens 12 . Other groups have independently developed analogous chemistries for the visualization of proteins [13] [14] [15] and RNAs 16 in expanded samples. We here review the progress in this rapidly developing and increasingly widely adopted technique. We discuss the principles of ExM, how ExM is being applied in biology and medicine, and future directions for the technology and its application.
All ExM protocol variants share a similar logical flow, essential for isotropic specimen expansion, that preserves biological information down to nanoscopic length scales (Fig. 1b) . The design of the chemistry is aimed at ensuring the greatest degree of isotropy possible during the expansion process. First, molecular handles are covalently attached to biomolecules and/or labels (Fig. 1b, step i ) that enable them to be bound to a swellable hydrogel synthesized throughout the specimen. Second, the specimen is immersed in a monomer solution (containing sodium acrylate) that reacts via free-radical polymerization to form a densely cross-linked (via the cross-linker N-N′ -methylenebisacrylamide) and highly penetrating polyelectrolyte hydrogel (sodium polyacrylate). This surrounds the biomolecules and/or labels, binding to the molecular handles so that the attached biomolecules and/or labels are mechanically coupled to the polymer mesh (Fig. 1b, step ii) . Third, the specimen is homogenized with respect to its mechanical properties by chemical denaturation via heat and detergent treatment, or by enzymatic digestion, as appropriate for the specimen and the molecules to be visualized (Fig. 1b, step iii) . Finally, the specimen is immersed in water, which diffuses into the polyelectrolyte hydrogel through osmotic force, causing swelling that is facilitated by the highly charged nature of the polyelectrolyte mesh. (Fig. 1b, step iv) . After expansion, further labels and/or amplification chemistries to improve visualization may be applied.
Most ExM protocols expand a biological specimen by about 100× in volume, or ~4.5× in the linear dimension; this factor is set by the cross-linker concentration (reduction of the cross-linker concentration results in greater gel expansion factors, but also greater gel fragility; recently a protocol using the additional monomer N,N-dimethylacrylamide acid during the polymerization step presented an ~10× linear expansion) 5, 15 . With 4.5× linear expansion, a microscope with a diffraction limit of ~300 nm would attain an effective resolution of ~300 nm/4.5 ≈ 70 nm. It is also possible to expand specimens twice in series, thus enabling an ~4.5 × 4.5 ≈ 20× increase in linear dimension, so that a conventional diffraction-limited microscope could achieve a resolution of 300/20 ≈ 15 nm (in practice, this value is slightly larger owing to the size of the fluorescent labels applied to the specimen before expansion) 11 , which is comparable to that of the best previous super-resolution methods for imaging of cells and tissues. Protocols are available on the web (http://expansionmicroscopy.org) and in step-by-step peerreviewed form 17 . ExM protocols have been empirically validated by comparison of the resulting images to those obtained via previous superresolution technologies (for example, structured illumination microscopy, stochastic optical reconstruction microscopy, and stimulated emission depletion microscopy) followed by analysis of the distortion that results from the expansion process via a nonrigid registration algorithm, as well as by examination of post-expansion images of highly stereotyped structures (e.g., microtubules) 5, 9, [11] [12] [13] 15, 18 . The protocols we describe all exhibit low distortions of a few percent over length scales of tens to hundreds of micrometers. From an enduser perspective, the sample-to-sample reliability for a well-tested protocol is consistent enough that new biological studies are able to use well-tested protocols without further validation, especially for a cell or tissue type that has been previously validated. For a cell or tissue type being explored for the first time, validation of isotropy via the aforementioned methods may be helpful. Because user error of course can occur, it is helpful to have a quick check to evaluate protocol success; in our experience, if the overall expansion factor for a new sample matches that described in the literature for that protocol and sample type, and if no cracks or apparent deformations Labeling of biomolecules can be done before step i or after step iii.
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) (note that this is an estimate of the error in the location of gel-anchored biomolecules introduced by polymerization and expansion that has not actually been achieved as a practical resolution to date, owing to the larger size of the labels (i.e., antibodies) used).
Because the ExM sample-preparation method enables nanoscale imaging with commonly available microscopes, it can be readily deployed in many contexts in biology and medicine. ExM also has other advantages. For example, because the final product is ~99% water, with endogenous material diluted 100× or more, it is transparent (Fig. 1c) , with nearly 100% light transmission through a 200-µ m-thick slice of expanded brain tissue 5 . This allows for the use of very fast imaging modalities such as light-sheet microscopy for large-volume nanoscopy 10, 19 . In addition, the expansion process is compatible with the visualization of a variety of biomolecules (for example, proteins (Fig. 1d,e) and RNA (Fig. 1g) ) with existing labels or stains, which means that it can push many existing techniques, such as the popular 'Brainbow' method of barcoding neurons in vivo with different fluorescent proteins or epitopes 9 ( Fig. 1f) , into the super-resolution realm.
Ever since our original demonstration of isotropic cell and tissue expansion in 2015, variants have been developed by our group and by other groups to enable the imaging of proteins labeled with conventional antibodies or fused to genetically encoded fluorophores (protein-retention ExM (proExM) protocols 9, [13] [14] [15] ), to support the imaging of RNAs labeled with fluorescence in situ hybridization (FISH) probes (expansion FISH (ExFISH) 10, 16 ), to enable extremely fine-resolution imaging through repeated expansion of a sample (iterative ExM (iExM) 11 ), and to study human specimens such as those generated for pathology and diagnosis purposes (expansion pathology (ExPath) 12 ). Interestingly, tissue expansion was sometimes commented on in early studies of brain clearing. For example, in 2011, the Scale brain-clearing protocol (involving chemicals such as urea and Triton X-100) was noted to cause 1.25× expansion of tissues 20 . Later brain-clearing protocols such as CUBIC 21 (also involving a cocktail of small-molecule chemicals) and CLARITY 22 (also involving uncharged polyacrylamide hydrogels) also commented on swelling of tissues thus treated. In these studies, however, expansion was treated as an uncontrolled and/or undesired process, and no attempts were made to design the strategy for isotropic expansion, or to analyze whether the strategy preserved nanoscale information. However, recently, an extension of CUBIC called CUBIC-X, which applies the small molecules imidazole and antipyrine to achieve swelling of CUBIC-processed tissue, was shown to swell brain tissue ~2× linearly, thus enabling subcellular-resolution imaging of entire mouse brains with light-sheet microscopy 23 .
ExM methods
Protein-retention expansion microscopy. The first version of ExM 5 (which we now call ExM 1.0) required end users to synthesize their own labeling reagents for tagging proteins of interest, which limited its utility for everyday biology contexts (although it was used for the visualization of biomolecules in Escherichia coli 24 ( Fig. 2a) ). In proExM 9 , in contrast, only off-the-shelf chemicals are needed to directly retain endogenous proteins and/or exogenous protein-based labels. Two other groups-the Vaughan lab and the Chung lab-independently developed related chemistries 13, 14 , which we describe in more detail below. In proExM, application of the succinimidyl ester of 6-((acryloyl)amino)hexanoic acid (acryloyl-X, SE; abbreviated as AcX) to a preserved specimen equips amines on proteins with a polymerizable carbon-carbon double bond 9 , which in turn enables proteins to be anchored to the polymer during the polymerization step (Fig. 1b) . The procedures below can take, depending on the protocol used and the size of the tissue to be processed, anywhere from a day to a week, with much of the time required being incubation time that permits chemical access to the tissue. Fluorescent labels for the visualization of proteins-for example, fluorescently tagged antibodies-can be applied either before or after expansion.
In the former case, standard fluorescent antibodies are applied to fixed cells or tissues before expansion occurs. Genetically encoded fluorophores, perhaps fused to proteins of interest, can also be expressed in living cells via viral delivery, transfection, or transgenesis. AcX binds to all the proteins, including the fluorescent antibodies and/or genetically encoded fluorophores. After polymerization, mechanical homogenization (Fig. 1b) is carried out by proteinase K, a powerful protease, applied at a dose that results in the destruction of the majority of the proteins that provide structural integrity to cells and tissues but spares the functions of the antibodies and fluorescent proteins 25, 26 . This is possible because many antibodies and fluorescent proteins are relatively protease resistant. After gelation, digestion, and expansion, the fluorescence of the antibody labels or fluorescent proteins is largely retained for many genetically encoded fluorophore and small-molecule dyes (Fig. 1d ,e), which allows for imaging of biomolecular identity and location (although the volumetric dilution due to expansion reduces the intensity per unit volume).
Most fluorescent dyes commonly used with antibodies are compatible with this process, with the exception of cyanine dyes, which are destroyed during polymerization (Fig. 1e) ; excellent alternatives to cyanine dyes are now available in spectral bands where cyanine dyes have been popular in the past 9 . Most GFP-like (i.e., β -barrelstructured) fluorescent proteins are also preserved in this process (Fig. 1d) ; infrared fluorescent proteins based on bacteriophytochromes, in contrast, are largely destroyed 9 . In addition to antibodies, other protease-resistant labels such as streptavidin can be applied pre-expansion 9 ; this approach has been used to enable visualization of post-translational modifications such as S-nitrosylation that can be marked by biotin-bearing small-molecule tags 9 . In parallel to our development of proExM, another group independently developed a related protocol 13 that uses methacrylic acid N-hydroxysuccinimidyl ester (MA-NHS, which is structurally similar to AcX) or glutaraldehyde to serve as an anchor that links fluorescent proteins and antibodies to the polymer. In this study, MA-NHS was demonstrated to work well in both cultured cells and tissue slices, and glutaraldehyde was used on cultured cells. In practice, the MA-NHS protocol is fairly similar to the AcX protocol described above, as the linkers are largely analogous to one another. Further tests of the glutaraldehyde protocol on intact tissues could be conducted in the future but have not been carried out yet, to our knowledge. In this study 13 , it was also shown that biotin-labeled antibodies could be used, with visualization enabled post-expansion by the application of fluorescent streptavidin, which allows for utilization of fluorophores that would have been destroyed by the expansion process, and elimination of polymerization-induced fluorophore destruction.
ProExM protocols using either AcX or MA-NHS have been validated on a wide range of fluorescent proteins and antibody-borne fluorophores, and applied to a diversity of proteins and structures (such as clathrin-coated pits, keratin fibers, actin filaments, vimentin, myelin, glial markers, chromosomes, kinetochores, mitochondria, peroxisomes, pre-and post-synaptic proteins, nuclear lamina, histones, and microtubules 9, 13, 18 ) in a variety of cell and tissue types (including many kinds of cultured cells, as well as mouse brain, pancreas, spleen, and lung; rhesus macaque brain; and larval zebrafish 9, 13, 18 (Fig. 2b) ). This family of protocols has very rapidly come to be used for nanoscale imaging of protein identity and location in a diversity of contexts, including for examinations of larval zebrafish brain synaptic connections and nuclear-cytoskeletal organization 18 , imaging of glial and gap junction organization in human brain tissue from subjects with epilepsy 27 , and imaging of synaptic proteins to characterize novel connections in mouse striatal brain circuitry (Fig. 2c) 
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, among many other biological investigations published at the time of this review's acceptance [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Another independent attempt at creating a fluorescent protein-retention form of ExM resulted in the protocol ePACT. This approach, in contrast to the other methods described in this section, does not use an explicit protein-anchoring chemical, and uses the milder enzyme collagenase for mechanical homogenization rather than proteinase K 44 . Although ePACT resulted in approximately fourfold expansion of Thy1-YFP + brain tissue, with YFP fluorescence visible, the authors 44 noted that this was accompanied by tissue destruction, including the compromising of fine processes. In comparison to the other procedures discussed in this section, it is possible that ePACT encounters these difficulties because of its lack of protein-anchoring treatment and the incomplete mechanical homogenization caused by the gentler protease.
In a second style of proExM, endogenous proteins are directly anchored to the polymer hydrogel via AcX and then stained with antibodies post-expansion 9 . In order for epitopes to be retained, the mechanical homogenization step does not involve protease digestion, but rather proceeds via a gentler homogenization protocol, such as treatment with a high-temperature detergent solution. Use of a gentler protease, such as LysC, which cuts proteins at lysines and thus yields protein fragments that can be of sufficient size to retain epitopes for antibody binding, can also work. After mechanical homogenization and expansion, the specimen can be stained with standard antibodies to allow imaging of proteins with nanoscale resolution (Fig. 3a) . In our hands, this protocol worked for many, but not all, antibodies tried, perhaps because epitopes were sometimes lost during heat treatment or during LysC cleavage; this protocol also sometimes led to discontinuities in processes and white matter tracts.
The magnified analysis of the proteome (MAP) protocol 14 , developed independently and in parallel to proExM, also allows for the retention and staining of epitopes after expansion, using somewhat different fixation, polymerization, and homogenization steps. In MAP, the expansion of gel-retained proteins away from each other is facilitated by reduction of the amount of cross-linking between proteins during formaldehyde fixation. This is achieved through the addition of acrylamide during fixation, which reacts to formaldehyde bound to proteins and prevents protein-protein cross-linking. An open question is how this reduction in cross-linking degree affects nanoscale ultrastructure-level organization. The bound acrylamide also serves to equip proteins with a gel anchorable moiety, as acrylamide can participate in free-radical polymerization just as acrylate does (and indeed, it was the original monomer used in the Hausen-Dreyer protocol 7 ). After immersion of the specimen in a mixture of sodium acrylate and acrylamide, and formation of the resulting interpenetrating gel throughout the specimen, incubation in a high-temperature detergent solution causes denaturation of proteins and allows for separation and expansion upon immersion of the specimen in water. Finally, epitopes are labeled via immunostaining after expansion. MAP was initially demonstrated on multiple organs, including heart, lung, liver, kidney, and brain, as well as on cerebral organoids. Post-expansion staining with MAP was demonstrated to work with > 80% of the > 100 antibodies tested, including antibodies to microtubules, neurofilaments, and a diversity of membrane, cytoplasmic, nuclear, and synaptic proteins 14 . MAP also allows for multiplexed antibody staining by the iterative staining and removal of antibodies; destaining involves immersion in a high-temperature denaturation solution. Whereas other proExM variants have focused on application to previously fixed tissue sections to facilitate diffusion of reagents into specimens, MAP achieves whole-organ expansion by delivering the necessary reagents (including fixatives) via transcardial perfusion and applying longer incubation times-an approach that potentially could be extended to other ExM methods. At the time of this paper's acceptance, MAP had been used to visualize the glomerular filtration barrier of the kidney in rodents 45 . It is essential to validate the performance of antibodies in order to achieve the highest-fidelity staining possible for post-expansion antibody administration. The use of other tags, such as Snap, Clip, and Halo tags, or the use of nanobodies may also improve the resolution enabled by proExM protocols even further, owing to their smaller size. Recent advancement in multiplexed stimulated Raman scattering has yielded sets of dyes that can be imaged a dozen or more at a time, and thus could also be adapted for multiplexed 145 µ m) ), or 500 µ m (h (1,450 µ m) ).
imaging of a large number of biomolecules simultaneously in a single ExM sample 46, 47 . Another area of future innovation is to rethink microscopy hardware so that the largest volumes possible can be imaged, taking advantage of the fact that expansion protocols can improve resolution in a way that is complementary and orthogonal to traditional microscope design. ProExM-like protocols result in specimens that can be imaged on many conventional microscopes, including the confocal microscopes and epifluorescent microscopes ubiquitous in biology and medicine. For general morphological visualization of cells and tissues, it is possible to expand samples with a proExM-like protocol and then image the resulting expanded samples via bright-field or phase-contrast microscopy to determine the location and organization of membranes and organelles 9 . Such a strategy has been used, for example, to visualize tunneling nanotubes between cultured epithelial cells, which can be exploited by the influenza virus to help it spread from cell to cell and potentially evade the immune system 48 . An exciting possibility just beginning to be explored is that post-expansion staining of specimens may allow for proteins to be decrowded by the expansion process, thereby improving the accessibility and density of staining for proteins even within a dense multicomponent complex.
Samples expanded with proExM have also been imaged with super-resolution microscopes for added resolution beyond what is achievable with conventional microscopes. The use of proExManchorable fluorescent proteins makes super-resolution photoactivated localization microscopy possible with expanded cells, potentially enabling very high-resolution imaging; the basic concept has been demonstrated with cultured cells expressing histone H3.3-Dendra2, but the fundamental resolution supported by this methodology has not been fully validated 9 . Other studies have applied super-resolution structured illumination microscopy 36, 40 or stimulated emission depletion microscopy 43, 45, 49 to samples (including microbes, cultured cells, mammalian tissues, and Drosophila tissues) expanded with proExM-like protocols. Finally, one group of researchers used the original ExM protocol on samples that they subsequently imaged with inexpensive modified webcams, and found that the resolution improvement enabled by ExM compensated for the poorer resolution of the low-cost microscopy hardware, thus potentially allowing for less expensive biological and medical imaging 24 .
Expansion pathology. ExPath is a variant of the pre-expansion antibody-administration proExM protocol optimized for tissue specimens common in human clinical and pathological settings 12 . Formalin-fixed paraffin-embedded, hematoxylin and eosin (H&E)-stained, and fresh-frozen thin-sliced specimens can be preprocessed for use in the proExM pipeline. ExPath starts with a series of steps that make clinically prepared tissues compatible with proExM, such as xylene removal of any paraffin and antigen retrieval in hot sodium citrate. The form of proExM that follows has increased levels of EDTA, which improves tissue digestion in clinical specimens that are sometimes very heavily fixed owing to long exposure to formalin. H&E stains are removed during this processing. For freshfrozen sections (e.g., acetone-fixed), one reduces the amount of AcX to avoid over-anchoring of specimens, because there are more free amines available in such specimens to bind anchors owing to the lack of aldehyde fixatives occupying amines. The ExPath protocol has been applied to human skin, lung, liver, breast, prostate, pancreas, ovary, kidney, and other tissues (Fig. 2d) preserved via a variety of strategies.
ExPath is compatible with antibody staining, as demonstrated by labeling of many different markers (vimentin, keratin, etc.) in a diversity of tissues, as well as post-expansion DNA FISH against genes (as demonstrated by labeling of Her2 in Her2 -and Her2 + breast cancer samples from human patients). ExPath reduces autofluorescence by up to an order of magnitude by diluting or eliminating contributors to autofluorescence while preserving information covalently anchored to the polymer. We demonstrated that ExPath could resolve structures in human specimens that traditionally require electron microscopy imaging for diagnosis, such as podocyte foot processes that are effaced in people with nephrotic kidney diseases (Fig. 2e) . Although electron microscopy has superior resolution compared with that of current expansion microscopy protocols, the processing time of ExPath is substantially shorter than that for electron microscopy, and the skills and equipment needed for ExPath are much less demanding compared with those required for electron microscopy. Using ExPath, we were able to greatly improve the performance of a machine learning diagnosis classifier on human breast biopsies. This is an exciting development because agreement between pathologists can be as low as 50% (ref. 50 ) on such early breast lesions. These initial clinical studies were small, so future studies involving large numbers of patients will be essential in order for the potential value of ExPath in the clinic to be fully understood.
ExFISH: nanoscale imaging of RNA with expansion microscopy. One powerful attribute of ExM is that it is compatible with the visualization of new molecule classes and the incorporation of new amplification and analysis chemistries (Fig. 3b,c) . For example, RNA molecules can be anchored to the swellable polymer by the molecule LabelX, a reagent formed from the reaction of two commercially available reagents 10 . LabelX possesses an alkylating group that reacts primarily to guanine bases in RNA and DNA, as well as a carbon-carbon bond that can be incorporated into the gel. Thus, specimens treated with LabelX can be expanded in an even way. The ability to stain RNA after expansion opens the door to the use of various FISH strategies to interrogate RNA location and identity; we call this suite of technologies ExFISH. We have shown that standard single-molecule FISH (smFISH) can be applied to cultured cells after expansion, thus allowing for imaging of the nanoscale organization of RNA molecules such as long noncoding RNAs (Fig. 1g) . The ability of expansion to decrowd RNA molecules improves the quantification of RNA abundance (Fig. 3d,e) . Furthermore, expansion supports multiplexed smFISH by allowing for the efficient delivery and removal of probes, thereby making it possible to read out the identity and location of multiple RNA molecules over time (Fig. 3f,g ). Another group developed a simple method for visualization of RNAs that involves the application of gel-anchorable fluorescent FISH probes before expansion; the probes are then anchored to the polymer and expanded away from each other 16 . This approach yielded an improved signal-tonoise ratio and more accurate RNA counts than obtained with samples in the unexpanded state 16 . This method does not directly retain RNAs themselves; rather, it retains only the probes applied, and so should be used only when the goal is to image specific transcripts post-expansion, as it will not be possible to wash probes in or out post-expansion.
We anticipate the use of ExFISH with a diversity of signal-amplification strategies to enable better imaging of single RNA molecules in large, intact tissues. Signal-amplification techniques such as hybridization chain reaction (HCR) [51] [52] [53] and rolling circle amplification 54, 55 produce bright signals by forming large assemblies of fluorophores, which can be easily detected. ExM invites the use of such techniques by creating room for such large assemblies of fluorophores. For instance, we used HCR with ExFISH (Fig. 3b) , which allowed for single-molecule-resolution visualization of RNA with nanoscale precision in thick brain tissues (Fig. 3h,i) . HCR-ExFISH allows the super-resolved localization of RNA molecules in small compartments, such as neural synapses, while making it possible to image them over large regions of tissue. HCR has also been used to amplify the fluorescence connected to an antibody, thereby enabling protein visualization with a three-orders-of-magnitude boost in brightness compared with that achieved with conventional antibody staining 53 . Future investigations of how ExFISH protocols could be used for visualization of the 3D configuration of the genome will be of great interest in the probing of epigenetic states, chromatin conformation, and other important determinants of cell fate, function, and health.
Iterative expansion microscopy. In iExM, a specimen is expanded (Fig. 1b) , a second swellable gel is synthesized in the space opened up by the first expansion, and the sample is expanded again 11 . The gel synthesized for the first expansion step is made with a chemically cleavable cross-linker, which is cleaved after the second gel is made, thus allowing for further expansion. Biomolecules or labels must also be transferred from the first gel to the second gel to ensure that no information is lost. One way to do this is to initially stain samples with antibodies bearing oligonucleotide barcodes, which are chemically anchored to the first-round expansion polymer. After the first round of expansion, complementary oligonucleotide strands are added, which hybridize to the gel-anchored initial barcodes. These complementary strands are then chemically anchored to the second-round expansion gel and further expanded away from each other. These strands can then be labeled with further hybridizing probes bearing fluorophores (Fig. 3c) , which allows for amplification that is greatly helpful given the ~10,000× volumetric dilution of biomolecules or labels relative to the starting condition.
The resolution offered by iExM is comparable to the resolution of the best super-resolution methods that have been applied to cells and tissues (Supplementary Table 1) , and thus permits powerful 3D imaging with nanoscale precision in thick specimens on conventional microscopes. The ~25-nm resolution possible with iExM can resolve pre-and postsynaptic proteins such as neurotransmitter receptors and scaffolding proteins within synapses (Fig. 4d,e) . Of particular interest is the idea that iExM may allow detailed reconstruction of dense brain circuitry (a theoretical study of this possibility is presented in ref. 56 ). Although the spatial resolution of iExM does not yet approach that of electron microscopy, the inherent multicolor nature of optical microscopy can allow multiple kinds of tags, each labeled with different colors, to be used in an intact-tissue nanoscopy context. Thus information represented by one color could, if insufficient for tracing of a neural circuit, be error-corrected by the information represented by a second color 56 . Preliminary studies using Brainbow-labeled mouse cortex suggest that iExM can support the visualization of spines and other compartments along neural processes over extended 3D volumes (Fig. 4a-c) .
Can such resolutions be achieved in a single expansion step? Reduction of the cross-linker concentration results in far greater gel expansion factors, but also greater gel fragility . A recently published protocol that uses the additional monomer N,Ndimethylacrylamide acid during the polymerization step presented an ~10× linear expansion 15 . In this method, termed X10 microscopy, N,N-dimethylacrylamide acid serves simultaneously as a monomer and as a cross-linker, replacing the commonly used cross-linker N,N′ -methylenebisacrylamide. This modification of the gel chemistry allows the hydrogel to swell up to tenfold in a single expansion step, yielding a resolution of ~25 nm. X10 was demonstrated to work in both cultured cells and mouse brain tissue. Isotropy measurements in cultured cells showed distortion levels similar to those observed with other ExM variants. X10 requires strong protease digestion for mechanical homogenization, which results in the loss of fluorescent protein markers. The authors mitigated this issue by applying fluorescently labeled antibodies to fluorescent protein targets. Like other ExM protocols, X10 will benefit from future validation and optimization; for example, the authors noted that their attempt to expand mouse spleen tissue with X10 resulted in fragmentation, which suggests that for tough tissues, further refinement will be beneficial 15 . One interesting question is how different ExM protocols might be combined. For example, can the iExM protocol be combined with ExFISH, so that ultraprecise volumetric visualization of RNAs in extended intact tissues is possible? Can iExM be combined with the post-expansion-antibody-administration forms of proExM and MAP, so that epitopes can be decrowded for denser and higher-resolution antibody staining? And can the procedure be automated, so that extremely high-throughput processing of cells and tissues is possible? These questions represent opportunities for biotechnological innovation in the next few years, and in turn for downstream biological and medical discovery.
outlook
We have tried to document the status of specific ExM protocols, as well as where they are headed. We now offer some general comments on the state and future of the entire tool suite, in terms of fundamental performance and limitations. Compared with conventional super-resolution microscopy (SRM) methods, ExM offers numerous technical advantages, such as the ability to perform 3D nanoscale imaging of thick fixed specimens, as well as speed and ease of use (Supplementary Table 1, Supplementary Note 1) . In addition, ExM yields transparent samples as a byproduct of its physical mechanism. In contrast to other clearing techniques, ExM clears samples via the expansion process, which results in a hydrogel composed mostly of water (Supplementary Table 2 , Supplementary Note 2). The clearest disadvantage of ExM is its incompatibility with live samples. In contrast to SRM methods, ExM poses unique considerations owing to its physical mechanism. The expansion achieved is designed to be isotropic, and measurements of isotropy with different ExM methods have shown that distortions arising from the expansion process are minimal, but not zero (Supplementary Table 1 , Supplementary Note 1).
Although iExM currently offers 3D nanoscale imaging in tissues with resolution comparable to that of the best-performing SRM techniques, it might be possible to achieve even higher levels of expansion and resolution by improving polymer composition and processing protocols. Already a proof-of-concept triple expansion has been demonstrated, resulting in ~53× linear expansion, although the resolution was not validated 11 . This might actually exceed the resolution of existing SRM technologies if antibodies or other labels are delivered post-expansion, thus reducing the resolution error introduced by the nonzero size of the tags that comes into play when the tags are delivered to a nonexpanded tissue.
Another area of future interest is the combination of multiple protocols. A unified protocol that enabled the visualization of DNA, RNA, proteins, and lipids could reveal the organization of complexes of multiple kinds of biomolecules. Already the combined use of protein-anchoring AcX and RNA-labeling LabelX has been used to visualize fluorescent proteins and FISH-labeled RNAs in the same sample 10 , and the ExPath protocol has been used for DNA FISH in concert with antibody labeling of proteins in the same sample 12 .
The combination of multimodal anchoring and labeling strategies with iExM is also an exciting future direction, and could potentially allow many biomolecules to be visualized in a single sample with extremely high resolution.
The aqueous nature of expanded specimens and the decrowding of biomolecules may open the door for highly multiplexed readout of molecular information with nanoscale precision. ExFISH has already been used for serial staining with multiple FISH probes for multiplexed imaging of different transcripts after RNA anchoring and expansion 10 . It may be possible to implement in intact tissues the use of barcoded, combinatorial RNA-FISH multiplexing approaches 57, 58 , such as MERFISH [59] [60] [61] and seqFISH 62 , in which coded FISH probes are administered serially to yield the location of exponentially increasing numbers of transcripts over many cycles of hybridization. The ability to follow individual transcripts over many rounds of hybridization would be facilitated by the decrowding of transcripts. Indeed, ExM has been used with MERFISH to visualize, with 10× higher density, members of an ~130-RNA library with nearly 100% detection efficiency in cultured cells 61 . The covalent anchoring of RNA to the polymer may also help support controlled enzymatic reactions such as fluorescent in situ sequencing of RNA 54, 55 . Such approaches would yield transcriptome data in conjunction with cell morphology, protein locations, and other biomolecular information, with nanoscale precision.
Such techniques could also be used to identify any biomolecular labels conjugated to oligonucleotide barcodes that are retained within the gel (as seen, for example, with the use of DNA-PAINTstyle probes 63 ). For instance, it may be possible to deliver antibodies to various targets, each bearing a unique oligonucleotide tag that can be read out after expansion via multiplexed FISH or in situ sequencing, thus providing location and identity information for very large numbers of proteins. This scheme could be extended to label any biomolecule with an oligonucleotide barcode that can be identified after expansion, thereby enabling the nanoscale mapping of biomolecules throughout specimens in a highly multiplexed fashion.
